Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 301 to 325 of 1145 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
845 increased increased luteinizing hormone level (MP:0005133) StAR-related lipid transfer protein 4 (PR:000015719) 1972: Increased, Steroidogenic acute regulatory protein (StAR)
844 increased StAR-related lipid transfer protein 4 (human) (PR:Q96DR4) None
843 increased estrogen secretion (GO:0035937) Estrogen (FMA:83376) 1973: Increased, estrogens
842 increased increased luteinizing hormone level (MP:0005133) StAR-related lipid transfer protein 3 (PR:000015718) 1972: Increased, Steroidogenic acute regulatory protein (StAR)
841 increased increased luteinizing hormone level (MP:0005133) steroidogenic factor 1 (PR:000011411) None
840 increased luteinizing hormone signaling pathway (GO:0042700) None
839 disrupted barrier epithelial cell (CL:0000073) 1931: Intestinal barrier, disruption
838 decreased Lymphopenia (HP:0001888) lymphocyte (CL:0000542) 1868: Hyperinflammation
837 increased Elevated C-reactive protein level (HP:0011227) C-reactive protein (PR:000005897) 1868: Hyperinflammation
836 increased lactate dehydrogenase activity (GO:0004457) 1868: Hyperinflammation
835 increased Increased serum ferritin (HP:0003281) Ferritin (CHEBI:82594) 1868: Hyperinflammation
834 increased Increased inflammatory response (HP:0012649) 1868: Hyperinflammation
833 increased tumor necrosis factor secretion (GO:1990774) tumor necrosis factor alpha (PR:000000134) 1868: Hyperinflammation
832 increased interleukin-1 beta production (GO:0032611) interleukin-1 beta (PR:000001136) 1868: Hyperinflammation
831 increased interleukin-6 production (GO:0032635) interleukin-6 (PR:000001393) 1868: Hyperinflammation
830 increased regulation of chronic inflammatory response (GO:0002676) 1868: Hyperinflammation
829 increased Increased inflammatory response (HP:0012649) interleukin-1 beta (PR:000001136) None
828 increased Increased inflammatory response (HP:0012649) tumor necrosis factor alpha (PR:000000134) None
827 increased Increased inflammatory response (HP:0012649) interleukin-6 (PR:000001393) None
826 increased chronic inflammatory response (GO:0002544) 1868: Hyperinflammation
825 abnormal otic vesicle formation (GO:0030916) 1930: altered, inner ear development
824 increased viral release from host cell (GO:0019076) 1939: Viral infection and host-to-host transmission, proliferated
823 increased synaptic transmission, glutamatergic (GO:0035249) L-glutamate(1-) (CHEBI:29985) 1350: Increased, glutamate
822 increased synaptic transmission, glutamatergic (GO:0035249) glutamate(1-) (CHEBI:14321) None
821 increased synaptic transmission, glutamatergic (GO:0035249) None